Concepedia

Spencer T. Lea

ST

5

Publications

283

Citations

5

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Houston Methodist

Spencer T. Lea is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, medicine, and immune regulation.

ORCID

Top concepts

Publications per year

2019–2024

5

Publications

5

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu et al. · Science Immunology · 2022 · 140 citations · Full text

, , +17

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

Casey R. Ager, Akash R. Boda, Kimal Rajapakshe et al. · Journal for ImmunoTherapy of Cancer · 2021 · 65 citations · Full text

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

Hinda Najem, Spencer T. Lea, Shashwat Tripathi et al. · Journal of Clinical Investigation · 2024 · 36 citations · Full text

, , +19

p73 regulates epidermal wound healing and induced keratinocyte programming

J. Scott Beeler, Clayton B. Marshall, Paula I. González-Ericsson et al. · PLoS ONE · 2019 · 28 citations · Full text

, , +16

Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease

Chao-Hsien Chen, Renee L. Chin, Genevieve Hartley et al. · Neuro-Oncology · 2023 · 14 citations · Full text

Rows per page

1–5 of 5